Novacyt
Designs and supplies molecular diagnostic tests and PCR kits for human, veterinary, and food safety.
ALNOV | PA
Overview
Corporate Details
- ISIN(s):
- FR0010397232 (+1 more)
- LEI:
- 213800BWAC2BF295EG28
- Country:
- France
- Address:
- 13 AVENUE MORANE SAULNIER, 78129 VELIZY-VILLACOUBLAY
- Website:
- https://novacyt.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Novacyt is an international molecular diagnostics company specializing in the design, manufacture, and global supply of in vitro and molecular diagnostic tests. The company provides a broad portfolio of integrated technologies, services, assays, and reagents, with a primary focus on genomic medicine. Its products serve a wide range of applications, including infectious diseases and oncology. Through its specialized business units, such as Primerdesign, Novacyt delivers real-time PCR kits and custom development solutions to a global customer base in human health, food safety, and veterinary diagnostics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-03 15:40 |
Declaration of Voting Results & Voting Rights Announcements
Liquidity Agreement Monthly Update and TVR
|
English | 23.6 KB | ||
| 2025-10-22 08:00 |
Report Publication Announcement
Strategy update & notice of investor presentation
|
English | 26.1 KB | ||
| 2025-10-01 17:00 |
Declaration of Voting Results & Voting Rights Announcements
Liquidity Agreement Monthly Update and TVR
|
English | 24.3 KB | ||
| 2025-09-18 08:00 |
Report Publication Announcement
Notice of Results
|
English | 20.7 KB | ||
| 2025-09-18 07:00 |
Report Publication Announcement
Information sur les résultats du 1er semestre 2025
|
French | 219.8 KB | ||
| 2025-09-15 08:00 |
Board/Management Information
Appointment of Joint Corporate Broker
|
English | 20.9 KB | ||
| 2025-09-15 07:00 |
Board/Management Information
Nomination d'un co-courtier pour l’entreprise
|
French | 218.9 KB | ||
| 2025-09-12 11:00 |
Legal Proceedings Report
Resolution re. Lab 21 HSE Prosecution
|
English | 22.3 KB | ||
| 2025-09-12 07:00 |
Legal Proceedings Report
Décision concernant les poursuites engagées par le HSE contre Lab 21
|
French | 223.3 KB | ||
| 2025-08-01 17:02 |
Declaration of Voting Results & Voting Rights Announcements
Liquidity Agreement Monthly Update & TVR
|
English | 23.7 KB | ||
| 2025-08-01 16:00 |
Declaration of Voting Results & Voting Rights Announcements
Information mensuelle sur le contrat de liquidité et sur le nombre total de dro…
|
French | 241.0 KB | ||
| 2025-07-29 08:00 |
Interim Report
Half-year trading update
|
English | 25.1 KB | ||
| 2025-07-15 08:00 |
Regulatory News Service
Launch of LightBench® Discover
|
English | 23.5 KB | ||
| 2025-07-15 07:00 |
Regulatory News Service
Lancement de LightBench® Discover
|
French | 247.4 KB | ||
| 2025-07-01 14:45 |
Transaction in Own Shares
Liquidity Agreement Monthly Update and TVR
|
English | 23.7 KB |
Automate Your Workflow. Get a real-time feed of all Novacyt filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Novacyt
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Novacyt via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
